Citrulline / L-Citrulline for Endurance

Verdict: Citrulline does not improve endurance performance

For aerobic endurance, the evidence indicates that citrulline (including citrulline malate) does not work: multiple meta-analyses and randomized trials consistently find no meaningful benefit on endurance capacity. It is graded Counter-Evidence because the highest-quality studies point clearly to a null effect.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

The grade rests on consistent negative findings at the top of the evidence hierarchy. Two systematic reviews with meta-analysis report essentially zero effect on aerobic endurance: pooled time-to-exhaustion SMD was 0.03 (95% CI -0.27 to 0.33) and time-to-completion SMD -0.07 in one analysis (PMID 37155582, n=158), while a second found aerobic-performance SMD 0.15 (p=0.08), with perceived exertion, VO2 kinetics, and blood lactate also non-significant (PMID 36079738). Because high-quality reviews are negative and concordant, lower-tier trials cannot overturn the verdict.

Randomized trials agree. An 8 g citrulline-malate crossover RCT showed no difference from placebo in time-to-exhaustion or power output (PMID 31994989, n=28), and a 2024 high-quality trial that directly compared L-citrulline, citrulline malate, and placebo found no benefit from either form (PMID 39662304, n=43). A critical review further noted that most citrulline-malate products failed quality control (roughly 1.1:1 to 1.6:1 malate ratio versus the labelled 2:1), confounding many earlier positive claims (PMID 34417881).

Regulators and health bodies offer no support. The EU EFSA position is unfavourable, with two Article 13(5) opinions concluding insufficient evidence of cause-and-effect and no authorised health claims; the US FDA lists citrulline only as a dietary-supplement ingredient with no endorsement, while the UK NHS and WHO do not address it, and NIH ODS and sports-nutrition guidance are cautious. Any positive signals are confined to short resistance or anaerobic repetition work, not aerobic endurance, and individual trials are small and acute, limiting generalizability.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.46
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
74%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L5 Clinical bodiesAuthoritative stance
0.46
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.462
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 negative 主導 (3 negative > 0 positive),下層 RCT 不能推翻
  4. apply_hec_override — HEC-1 高階證據 negative — 強制由 C 改為 D
  5. tier_strict_requirement_check — Tier 條件達標,未降階
  6. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  7. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Effects of citrulline on endurance performance in young healthy adults: a systematic review and meta-analysis
PMID: 37155582 2023 統合分析 n = 158
Finding: No significant benefit: TTE pooled SMD = 0.03 (95% CI -0.27 to 0.33); TTC pooled SMD = -0.07 (95% CI -0.50 to 0.15); both CIs crossed zero.
Academic Effect size: SMD 0.03 (TTE); SMD -0.07 (TTC)
View on PubMed
Effects of Citrulline Supplementation on Different Aerobic Exercise Performance Outcomes: A Systematic Review and Meta-Analysis
PMID: 36079738 2022 統合分析
Finding: No significant benefit on aerobic performance (SMD = 0.15, 95% CI -0.02 to 0.32, p = 0.08); RPE, VO2 kinetics, and lactate also non-significant.
Effect size: SMD 0.15 (p = 0.08)
View on PubMed
A critical review of citrulline malate supplementation and exercise performance
PMID: 34417881 2021 系統性回顧
Finding: Cycling/aerobic studies consistently null (Glenn 2017: 8g CM no Wingate benefit; Gills 2021: no TTE benefit at 90% VO2peak, p=0.94); most CM products failed QC with ~1.1:1 to 1.6:1 ratio vs labelled 2:1, confounding dose estimates.
Academic
View on PubMed
Acute citrulline-malate supplementation is ineffective during aerobic cycling and subsequent anaerobic performance in recreationally active males
PMID: 31994989 2021 RCT (double-blind) n = 28
Finding: No significant differences from placebo on TTE, total work, mean watts, peak watts, or fatigue index (all p > 0.05).
View on PubMed
Malate or Not? Acute Effects of L-Citrulline Versus Citrulline Malate on Neuromuscular Performance in Young, Trained Adults: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial
PMID: 39662304 2024 RCT (double-blind) n = 43
Finding: Neither L-citrulline nor citrulline malate enhanced any performance measure vs placebo (all p ≥ 0.061); directly compares the two forms.
🟢 High quality
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
相關作用機轉仍在科學研究階段(the related mechanism of action remains in the scientific research stage);目前西瓜的壯陽效果尚不確定(watermelon's purported enhancement effects remain unconfirmed)。台灣食品法規好像沒有把這個成分列為可添加用途。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Neutral
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-endurance-INT-citrulline-001 繁體中文版 →